Drake & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Drake & Associates's ABBV Position: Q3 2026 in Review
Drake & Associates increased its AbbVie (ABBV) stake by 0.17% in Q3 2026, buying an estimated $3.59K and bringing the position to 8,082 shares worth $2.11M. The position accounts for 0.33% of the portfolio, ranked #24.
Drake & Associates first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Drake & Associates held 8,082 shares of AbbVie worth $2.11M as of Q3 2026.
- Drake & Associates bought 14 AbbVie shares in Q3 2026, an estimated $3.59K.
- AbbVie made up 0.33% of Drake & Associates's portfolio in Q3 2026, its #24 holding.
- Drake & Associates first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
- 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Drake & Associates's 13F filing for Q3 2026, filed 18 Nov 2026.